Filed: 8/14/2024ACC: 0001974915-24-000006
📋 What this filing means
VESTAL POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 60 equity positions with a total reported market value of $1.34B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
60
Positions
$1.34B
Total AUM (reported)
79.31M
Total Shares
Allocation by class
COM$614.98M45.9%
COM NEW$168.64M12.6%
SHS USD$160.09M11.9%
SPONSORED ADR$152.22M11.4%
CL A$61.64M4.6%
SHS$53.23M4.0%
COM PAR $.01$50.25M3.7%
Portfolio Concentration
Top 3$374.80M27.9%
4–10$361.10M26.9%
11–25$367.00M27.4%
Rest$238.23M17.8%
Top 3 weight
27.9%
Top 10 weight
54.9%
Voting Authority Distribution
Total shares with voting rights: 79.31M
Sole
Full voting authority
79.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole60
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings60
Rows:
Jazz Pharmaceuticals PLC
SOLEShares1.50M
TypeSH
Market value$160.09M
11.94%
Sole
1.50M
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares2.08M
TypeSH
Market value$112.42M
8.38%
Sole
2.08M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares750K
TypeSH
Market value$102.28M
7.63%
Sole
750K
Shared
0.00
None
0.00
Ultragenyx Pharmaceutical Inc
SOLEShares1.80M
TypeSH
Market value$73.98M
5.52%
Sole
1.80M
Shared
0.00
None
0.00
Globus Medical Inc
SOLEShares900K
TypeSH
Market value$61.64M
4.60%
Sole
900K
Shared
0.00
None
0.00
Insmed Inc
SOLEShares750K
TypeSH
Market value$50.25M
3.75%
Sole
750K
Shared
0.00
None
0.00
BeiGene Ltd
SOLEShares350K
TypeSH
Market value$49.93M
3.72%
Sole
350K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares1.20M
TypeSH
Market value$48.96M
3.65%
Sole
1.20M
Shared
0.00
None
0.00
Exact Sciences Corp
SOLEShares925K
TypeSH
Market value$39.08M
2.91%
Sole
925K
Shared
0.00
None
0.00
Arcellx Inc
SOLEShares675K
TypeSH
Market value$37.25M
2.78%
Sole
675K
Shared
0.00
None
0.00
Immatics NV
SOLEShares2.75M
TypeSH
Market value$31.95M
2.38%
Sole
2.75M
Shared
0.00
None
0.00
Janux Therapeutics Inc
SOLEShares725K
TypeSH
Market value$30.37M
2.26%
Sole
725K
Shared
0.00
None
0.00
Astria Therapeutics Inc
SOLEShares3.25M
TypeSH
Market value$29.57M
2.21%
Sole
3.25M
Shared
0.00
None
0.00
KalVista Pharmaceuticals Inc
SOLEShares2.30M
TypeSH
Market value$27.09M
2.02%
Sole
2.30M
Shared
0.00
None
0.00
Savara Inc
SOLEShares6.49M
TypeSH
Market value$26.15M
1.95%
Sole
6.49M
Shared
0.00
None
0.00
iTeos Therapeutics Inc
SOLEShares1.75M
TypeSH
Market value$25.97M
1.94%
Sole
1.75M
Shared
0.00
None
0.00
Applied Therapeutics Inc
SOLEShares5.43M
TypeSH
Market value$25.36M
1.89%
Sole
5.43M
Shared
0.00
None
0.00
Axsome Therapeutics Inc
SOLEShares300K
TypeSH
Market value$24.15M
1.80%
Sole
300K
Shared
0.00
None
0.00
Structure Therapeutics Inc
SOLEShares560K
TypeSH
Market value$21.99M
1.64%
Sole
560K
Shared
0.00
None
0.00
Liquidia Corp
SOLEShares1.83M
TypeSH
Market value$21.96M
1.64%
Sole
1.83M
Shared
0.00
None
0.00
ALX Oncology Holdings Inc
SOLEShares3.60M
TypeSH
Market value$21.71M
1.62%
Sole
3.60M
Shared
0.00
None
0.00
uniQure NV
SOLEShares4.75M
TypeSH
Market value$21.28M
1.59%
Sole
4.75M
Shared
0.00
None
0.00
Bristol-Myers Squibb Co
SOLEShares500K
TypeSH
Market value$20.77M
1.55%
Sole
500K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares525K
TypeSH
Market value$20.47M
1.53%
Sole
525K
Shared
0.00
None
0.00
Praxis Precision Medicines Inc
SOLEShares440K
TypeSH
Market value$18.20M
1.36%
Sole
440K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCSOLE | SHS USD | 1.50M | SH | $160.09M 11.94% | 1.50M | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM NEW | 2.08M | SH | $112.42M 8.38% | 2.08M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 750K | SH | $102.28M 7.63% | 750K | 0.00 | 0.00 |
Ultragenyx Pharmaceutical IncSOLE | COM | 1.80M | SH | $73.98M 5.52% | 1.80M | 0.00 | 0.00 |
Globus Medical IncSOLE | CL A | 900K | SH | $61.64M 4.60% | 900K | 0.00 | 0.00 |
Insmed IncSOLE | COM PAR $.01 | 750K | SH | $50.25M 3.75% | 750K | 0.00 | 0.00 |
BeiGene LtdSOLE | SPONSORED ADR | 350K | SH | $49.93M 3.72% | 350K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 1.20M | SH | $48.96M 3.65% | 1.20M | 0.00 | 0.00 |
Exact Sciences CorpSOLE | COM | 925K | SH | $39.08M 2.91% | 925K | 0.00 | 0.00 |
Arcellx IncSOLE | COMMON STOCK | 675K | SH | $37.25M 2.78% | 675K | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 2.75M | SH | $31.95M 2.38% | 2.75M | 0.00 | 0.00 |
Janux Therapeutics IncSOLE | COM | 725K | SH | $30.37M 2.26% | 725K | 0.00 | 0.00 |
Astria Therapeutics IncSOLE | COM | 3.25M | SH | $29.57M 2.21% | 3.25M | 0.00 | 0.00 |
KalVista Pharmaceuticals IncSOLE | COM | 2.30M | SH | $27.09M 2.02% | 2.30M | 0.00 | 0.00 |
Savara IncSOLE | COM | 6.49M | SH | $26.15M 1.95% | 6.49M | 0.00 | 0.00 |
iTeos Therapeutics IncSOLE | COM | 1.75M | SH | $25.97M 1.94% | 1.75M | 0.00 | 0.00 |
Applied Therapeutics IncSOLE | COM | 5.43M | SH | $25.36M 1.89% | 5.43M | 0.00 | 0.00 |
Axsome Therapeutics IncSOLE | COM | 300K | SH | $24.15M 1.80% | 300K | 0.00 | 0.00 |
Structure Therapeutics IncSOLE | SPONSORED ADS | 560K | SH | $21.99M 1.64% | 560K | 0.00 | 0.00 |
Liquidia CorpSOLE | COM NEW | 1.83M | SH | $21.96M 1.64% | 1.83M | 0.00 | 0.00 |
ALX Oncology Holdings IncSOLE | COM | 3.60M | SH | $21.71M 1.62% | 3.60M | 0.00 | 0.00 |
uniQure NVSOLE | SHS | 4.75M | SH | $21.28M 1.59% | 4.75M | 0.00 | 0.00 |
Bristol-Myers Squibb CoSOLE | COM | 500K | SH | $20.77M 1.55% | 500K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | COM | 525K | SH | $20.47M 1.53% | 525K | 0.00 | 0.00 |
Praxis Precision Medicines IncSOLE | COM NEW | 440K | SH | $18.20M 1.36% | 440K | 0.00 | 0.00 |
Page 1 of 3